In the study, Banerjee et al. studied eight AD patients who had received a c-hGH injection prepared with a method known as the Wilhelmi or Hartree-modified Wilhelmi preparation (HWP), which has been implicated in all cases of iatrogenic CJD within the United Kingdom [13,14]. The gene discussed is GH1; the disease is Alzheimer disease.